News
ASRT
0.7851
-9.30%
-0.0805
Weekly Report: what happened at ASRT last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at ASRT last week (0408-0412)?
Weekly Report · 04/15 11:11
Weekly Report: what happened at ASRT last week (0401-0405)?
Weekly Report · 04/08 11:17
*Assertio Names Sig Kirk to Bd of Directors
Dow Jones · 04/03 12:01
SIG KIRK JOINS ASSERTIO BOARD OF DIRECTORS
Reuters · 04/03 12:00
Press Release: Sig Kirk Joins Assertio Board of Directors
Sig Kirk is a senior corporate business development executive with more than 20 years of pharmaceutical experience. He will serve on the Audit and Compensation committees of Assertio's board of directors. Kirk's appointment is part of the company's commitment to aligning board expertise with business strategies.
Dow Jones · 04/03 12:00
Assertio Holdings Chairman Declines Reelection Amid Disputes
TipRanks · 04/02 21:23
Weekly Report: what happened at ASRT last week (0325-0329)?
Weekly Report · 04/01 11:14
Assertio to Present at LD Micro Invitational Conference in New York City
Ajay Patel, Chief Financial Officer, will present at the LD Micro Invitational XIV Conference to be held April 9, 2024 in New York City. Assertio Holdings, Inc. Is a pharmaceutical company with comprehensive commercial capabilities. The conference will be held in April 2024.
Barchart · 04/01 08:00
Weekly Report: what happened at ASRT last week (0318-0322)?
Weekly Report · 03/25 11:17
Weekly Report: what happened at ASRT last week (0311-0315)?
Weekly Report · 03/18 11:16
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Asana, Inc. Fell 11% to $16.72 on Tuesday. Asana reported soft FY25 revenue guidance. ClearOne, Inc., rose 168.4% in the mid-day session. Regulus Therapeutics Inc. Shares rose 74.3% after posting strong quarterly results.
Benzinga · 03/12 18:07
Assertio Holdings Is Maintained at Buy by Lake Street
Dow Jones · 03/12 16:22
Assertio Holdings Price Target Cut to $3.00/Share From $4.00 by Lake Street
Dow Jones · 03/12 16:22
Lake Street Maintains Buy on Assertio Holdings, Lowers Price Target to $3
Benzinga · 03/12 16:12
Assertio Holdings files for $150M mixed shelf
Seeking Alpha · 03/12 14:04
Assertio Therapeutics Welcomes Sigurd Kirk to Board
TipRanks · 03/11 21:22
Recap: Assertio Holdings Q4 Earnings
Assertio Holdings reported its Q4 earnings of $0.11 on March 11. The company's revenue was down $17.37 million from the same period last year. Assertio held to a beat on earnings by 650.0%. The company is expected to report its earnings on March 14, 2024.
Benzinga · 03/11 20:05
Assertio Holdings Q4 2023 Adj EPS $0.11 Beats $(0.02) Estimate, Sales $32.985M Miss $33.813M Estimate
Assertio Holdings reported quarterly earnings of $0.11 per share. The company reported quarterly sales of $32.985 million which missed the analyst consensus estimate of $33.813 million by 2.45%. The company's sales for the quarter were a 34.49 percent decrease over the same period last year.
Benzinga · 03/11 20:04
*Assertio Holdings Appoints Sigurd Kirk as an Independent Director, Effective April 3, 2024 >ASRT
Dow Jones · 03/11 20:04
More
Webull provides a variety of real-time ASRT stock news. You can receive the latest news about Assertio Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About ASRT
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).